Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Cardiovascular Pharmacology and Therapeutics|August 29, 2012
Telmisartan prevents excess-salt-induced exacerbated (malignant) hypertension in spontaneously hypertensive ratsDinko Susic, Hassan Fares, Edward D FrohlichOchsner Journal|May 24, 2011
Salt, arterial pressure, and cardiovascular and renal damageDinko Susic, Hassan Fares, Edward D FrohlichJournal of the American Society of Hypertension : JASH|September 22, 2012
Nebivolol prevents myocardial fibrosis and diastolic dysfunction in salt-loaded spontaneously hypertensive ratsDinko Susic, Hassan Fares, Edward D FrohlichPostgraduate Medicine|March 23, 2012
Vasodilating versus first-generation β-blockers for cardiovascular protectionHassan Fares, Carl J Lavie, Hector O VenturaOpen Heart|October 19, 2016
Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomesHassan Fares, James J DiNicolantonio, James H O'Keefe, et al.Mayo Clinic Proceedings|April 20, 2013
L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysisJames J DiNicolantonio, Carl J Lavie, Hassan Fares, et al.The American Journal of Cardiology|January 8, 2013
Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol)James J DiNicolantonio, Carl J Lavie, Hassan Fares, et al.Current Atherosclerosis Reports|January 8, 2014
Omega-3 fatty acids: a growing ocean of choicesHassan Fares, Carl J Lavie, James J DiNicolantonio, et al.Therapeutics and Clinical Risk Management|July 17, 2014
Icosapent ethyl for the treatment of severe hypertriglyceridemiaHassan Fares, Carl J Lavie, James J DiNicolantonio, et al.The American Journal of Cardiology|July 6, 2013
Meta-analysis of cilostazol versus aspirin for the secondary prevention of strokeJames J Dinicolantonio, Carl J Lavie, Hassan Fares, et al.Pageof 2